Fig. 1.
New avenues for nanoparticle-related therapies. Potential application of nanodrug formulations for clinical situations less relies on passive enhanced permeability and retention (EPR) effects
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.